Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 May 7;61(18):1860-70.
doi: 10.1016/j.jacc.2013.02.014. Epub 2013 Mar 7.

Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction

Julio A Panza  1 , Thomas A Holly, Federico M Asch, Lilin She, Patricia A Pellikka, Eric J Velazquez, Kerry L Lee, Salvador Borges-Neto, Pedro S Farsky, Robert H Jones, Daniel S Berman, Robert O Bonow
Affiliations
Randomized Controlled Trial

Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction

Julio A Panza et al. J Am Coll Cardiol. .

Abstract

Objectives: The study objectives were to test the hypotheses that ischemia during stress testing has prognostic value and identifies those patients with coronary artery disease (CAD) with left ventricular (LV) dysfunction who derive the greatest benefit from coronary artery bypass grafting (CABG) compared with medical therapy.

Background: The clinical significance of stress-induced ischemia in patients with CAD and moderately to severely reduced LV ejection fraction (EF) is largely unknown.

Methods: The STICH (Surgical Treatment for IsChemic Heart Failure) trial randomized patients with CAD and EF ≤35% to CABG or medical therapy. In the current study, we assessed the outcomes of those STICH patients who underwent a radionuclide (RN) stress test or a dobutamine stress echocardiogram (DSE). A test was considered positive for ischemia by RN testing if the summed difference score (difference in tracer activity between stress and rest) was ≥4 or if ≥2 of 16 segments were ischemic during DSE. Clinical endpoints were assessed by intention to treat during a median follow-up of 56 months.

Results: Of the 399 study patients (51 women, mean EF 26 ± 8%), 197 were randomized to CABG and 202 were randomized to medical therapy. Myocardial ischemia was induced during stress testing in 256 patients (64% of the study population). Patients with and without ischemia were similar in age, multivessel CAD, previous myocardial infarction, LV EF, LV volumes, and treatment allocation (all p = NS). There was no difference between patients with and without ischemia in all-cause mortality (hazard ratio: 1.08; 95% confidence interval: 0.77 to 1.50; p = 0.66), cardiovascular mortality, or all-cause mortality plus cardiovascular hospitalization. There was no interaction between ischemia and treatment for any clinical endpoint.

Conclusions: In CAD with severe LV dysfunction, inducible myocardial ischemia does not identify patients with worse prognosis or those with greater benefit from CABG over optimal medical therapy. (Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease [STICH]; NCT00023595).

PubMed Disclaimer

Figures

Figure 1
Figure 1. Kaplan-Meier rate estimates of all-cause mortality (panel A), cardiovascular mortality (panel B), and all-cause mortality or cardiovascular hospitalization (panel C)
The 813 STICH patients with no evaluable stress testing and hence excluded from this study are shown on the left panels. The 399 patients with stress testing included in this study are shown on the right panels. Analysis based on intention-to-treat. MED= medical therapy; CABG= coronary artery bypass graft surgery.
Figure 1
Figure 1. Kaplan-Meier rate estimates of all-cause mortality (panel A), cardiovascular mortality (panel B), and all-cause mortality or cardiovascular hospitalization (panel C)
The 813 STICH patients with no evaluable stress testing and hence excluded from this study are shown on the left panels. The 399 patients with stress testing included in this study are shown on the right panels. Analysis based on intention-to-treat. MED= medical therapy; CABG= coronary artery bypass graft surgery.
Figure 1
Figure 1. Kaplan-Meier rate estimates of all-cause mortality (panel A), cardiovascular mortality (panel B), and all-cause mortality or cardiovascular hospitalization (panel C)
The 813 STICH patients with no evaluable stress testing and hence excluded from this study are shown on the left panels. The 399 patients with stress testing included in this study are shown on the right panels. Analysis based on intention-to-treat. MED= medical therapy; CABG= coronary artery bypass graft surgery.
Figure 2
Figure 2. Kaplan-Meier estimates of all-cause mortality rates
Study patients are divided according to the presence or absence of ischemia on stress testing, regardless of treatment allocation.
Figure 3
Figure 3. Kaplan-Meier rate estimates of cardiovascular mortality (panel A) and all-cause mortality plus cardiovascular hospitalization (panel B)
Study patients are divided according to the presence or absence of ischemia on stress testing, regardless of treatment allocation.
Figure 3
Figure 3. Kaplan-Meier rate estimates of cardiovascular mortality (panel A) and all-cause mortality plus cardiovascular hospitalization (panel B)
Study patients are divided according to the presence or absence of ischemia on stress testing, regardless of treatment allocation.
Figure 4
Figure 4. Kaplan-Meier estimates of all-cause mortality rates according to treatment among patients with (right panel) or without (left panel) ischemia
Analysis based on intention-to-treat. MED= medical therapy; CABG= coronary artery bypass graft surgery.
Figure 5
Figure 5. Kaplan-Meier rate estimates of cardiovascular mortality (panel A) and all-cause mortality plus cardiovascular hospitalization (panel B) according to treatment among patients with (right panels) or without (left panels) ischemia
Analysis based on intention-to-treat. MED= medical therapy; CABG= coronary artery bypass graft surgery.
Figure 5
Figure 5. Kaplan-Meier rate estimates of cardiovascular mortality (panel A) and all-cause mortality plus cardiovascular hospitalization (panel B) according to treatment among patients with (right panels) or without (left panels) ischemia
Analysis based on intention-to-treat. MED= medical therapy; CABG= coronary artery bypass graft surgery.
See this image and copyright information in PMC

Comment in

  • Is ischemia dead after STICH?
    Gibbons RJ, Miller TD. Gibbons RJ, et al. J Am Coll Cardiol. 2013 May 7;61(18):1871-3. doi: 10.1016/j.jacc.2013.02.018. Epub 2013 Mar 7. J Am Coll Cardiol. 2013. PMID: 23500324 No abstract available.
  • Reply: Is ischemia really bad for you?
    Panza JA, Bonow RO. Panza JA, et al. J Am Coll Cardiol. 2013 Dec 3;62(22):2149. doi: 10.1016/j.jacc.2013.07.060. Epub 2013 Aug 28. J Am Coll Cardiol. 2013. PMID: 23994400 No abstract available.
  • Is ischemia really bad for you?
    Joshi NV, Dweck MR. Joshi NV, et al. J Am Coll Cardiol. 2013 Dec 3;62(22):2148-9. doi: 10.1016/j.jacc.2013.06.056. Epub 2013 Aug 28. J Am Coll Cardiol. 2013. PMID: 23994408 No abstract available.

References

    1. Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease. J Am Coll Cardiol. 2012;60:2564–603. - PubMed
    1. Fox K, Garcia MAA, Ardissino D, et al. Guidelines on the management of stable angina pectoris: executive summary. The task force on the management of stable angina pectoris of the European Society of Cardiology. Eur Heart J. 2006;27:1341–81. - PubMed
    1. Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2012;59:857–81. - PubMed
    1. Weiner DA, Ryan TJ, McCabe CH, et al. The role of exercise testing in identifying patients with improved survival after coronary artery bypass surgery. J Am Coll Cardio. 1986;8:741–8. - PubMed
    1. Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117:1283–91. - PubMed

Publication types

MeSH terms

Substances

Associated data